SCHEMBL4703274

SCHEMBL4703274

C[C@H]1C[C@@H](C(=O)NCC#N)N(c2cc(-c3ccc(CN(C)C)cc3)ccc2Cl)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.37
TAAR1 Q96RJ0 1/20 0.34
PARP1 P09874 1/20 0.33
PARP2 Q9UGN5 1/20 0.33
CTSK P43235 2/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
S1PR1 P21453 1/20 0.32
S1PR5 Q9H228 1/20 0.32
LCK P06239 1/20 0.32
ITK Q08881 1/20 0.32
CTSS P25774 3/20 0.32
CTSL P07711 1/20 0.32
P2RX7 Q99572 2/20 0.32
MELK Q14680 2/20 0.31
ENPP2 Q13822 1/20 0.31
HRH3 Q9Y5N1 2/20 0.31
HRH4 Q9H3N8 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC1 Q13547 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4759027 1.00 GRM2 (0.37) GRM2TAAR1PARP1PARP2CTSK
SCHEMBL4699857 0.90 BRD4 (0.36) GRM2CTSKS1PR1S1PR5CTSS
SCHEMBL4703179 0.88 ENPP2 (0.37) GRM2ENPP2
SCHEMBL4755888 0.88 BRD4 (0.38) CTSKCTSSCTSLCNR1
SCHEMBL4701812 0.88 BRD4 (0.38) CTSKCTSSCTSLCNR1
SCHEMBL4702352 0.88 KDM4E (0.36) CTSKCTSSCTSLP2RX7
SCHEMBL4704142 0.85 CTSK (0.41) CTSKCTSSCTSL
SCHEMBL4699988 0.85 P2RX7 (0.34) CTSKCTSSCTSLP2RX7
SCHEMBL4698830 0.84 CTSK (0.40) CTSKCTSSCTSL
SCHEMBL4701938 0.84 USP30 (0.36) CTSKCTSSCTSLP2RX7HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1372655-B1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK FROSST CANADA LTD (CA) 2008-10-01 EP claimed
US-7012075-B2 Cathepsin cysteine protease inhibitors MERCK & CO., INC. (US) 2006-03-14 US claimed
US-20040198982-A1 Cathepsin cysteine protease inhibitors MERCK CANADA INC. (CA) 2004-10-07 US claimed
EP-1372655-B1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK FROSST CANADA LTD (CA) 2008-10-01 EP disclosed
US-7012075-B2 Cathepsin cysteine protease inhibitors MERCK & CO., INC. (US) 2006-03-14 US disclosed
US-20040198982-A1 Cathepsin cysteine protease inhibitors MERCK CANADA INC. (CA) 2004-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198982-A1 Cathepsin cysteine protease inhibitors CTSB, CTSS, CTSZ GRM2 4761/4885TAAR1 4771/4885PARP1 3963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.